Open calls for funding

ITEA is an industry-driven European ecosystem for collaborative R&D projects on software-intensive systems. ITEA projects cover all topics related to software innovation, including:

• Artificial intelligence (e.g. large language models and other generative AI)
• Smart healthcare
• Cybersecurity (digital safety and security)
• Industry 4.0 and smart engineering, including simulation tools, digital twins, robotics and IoT
• Sustainability, including smart mobility and smart cities

Participating countries include Austria, Belgium (Flanders: VLAIO; Brussels: Innoviris; Wallonia: SPW), Canada, the Czech Republic, Germany, Denmark, Spain, Estonia, Finland, France, the United Kingdom, Hungary, South Korea, Lithuania, the Netherlands, Portugal, Romania, Sweden and Turkey.

Deadline: 10 November 2025 (concept); 29 May 2026 (full proposal)

More information

This fourth joint call for proposals is based on the 10 research priorities identified in 2022 by the Cystic Fibrosis Trust*.

*https://www.cysticfibrosis.org.uk/research/your-cf-research-priorities.

The call consists of several stages. Stage 1: preproposal & eligibility check: does the research proposal adressess at least one of the defined priorities?

The preselected projects will be invited to introduce a full proposal (stage 2).

Budget: 100.000 – 300.000 euro
Deadline: 13 November 2025

More information

Webinar will be organised for more details on 10/11/2025.

Deadline: 14 November 2025

More information

The Fund Marie-Thérèse De Lava and the Fund Robert Schneider wish to foster research in geriatric medicine, which plays an increasing role in health care. Both Funds aim to encourage high level researchers to develop their career by combining scientific research in geriatrics with clinical practice.

The support of max. 140.000 € over a period of 3 years, should enable a promising researcher in geriatrics to develop his own research line and to anchor his longer-term research vision. The research will focus on improving health, well-being and quality of life of older adults.

Budget: 50.000 – 150.000 euro
Deadline: 25 November 2025

More information

The call will officially open in December 2025. Detailed information on eligibility, guidelines, and application procedures will be published on the dedicated call website in the coming months. A webinar and Q&A session will also be organised to support prospective applicants.

The Philippe and Paul Claes Fund was established on the initiative of Paul Claes and his brother Philippe. Paul Claes had suffered from a rare disease since his teenage years. He was severely limited in his activities and often had to go to hospital for treatment. Despite this disability, he was determined to remain independent and lead an active social life. This was a daily challenge for him, but at the same time he felt well supported by those around him, both in his private and professional life. After Paul’s death in 2023, the Philippe and Paul Claes Fund was activated within the King Baudouin Foundation. The Fund aims to encourage and finance initiatives that make the lives of people with disabilities resulting from rare diseases, and those of their families, easier, more pleasant and richer.

This second call for projects focuses on a wide range of initiatives in Belgium that improve the quality of life of people with severe disabilities. The disability may be physical, mental or emotional, but must be directly related to a rare disease as defined by the European Union (in the EU, a rare disease is defined as a disease that affects less than 5 in 10,000 people in the general population)*. The initiatives must alleviate the physical, mental, emotional or other disabilities of these people and their environment. They must support them in fully realising their personal, social and/or professional potential.

Budget: 2.500 – 17.500 euro
Deadline: 04 December 2025

More information

On 10 December 2025, ERDERA will launch its 2026 Joint Transnational Call, “Resolving unsolved cases in rare genetic and non‑genetic diseases through variant validation and new technological approaches”.

The call will welcome proposals focused on providing diagnostic clarity in unsolved rare genetic and non‑genetic diseases.

This call’s  pre‑announcement is available below, and it describes the forthcoming opportunity for multinational research teams to apply and will be updated with the full call when it launches.

An information webinar for potential applicants will take place on 16 December, 15:00–17:00 CET. Register for the webinar through this link.

Involving patient organisations from the very start is highly desirable. Should you need guidance about patient involvement in research, have a look at this guide.

Adolescence is a crucial period of self-discovery and discovery of others, but this very specific and enriching stage has its own particular challenges: Teenagers question their own existence and often seek to develop their strengths and abilities, realise their potential and live life to the full, which drives them to nurture and grow what is alive within them.

They renew their sense of existence and identity by exploring, accepting and embracing their rapidly changing bodies. Body-based practices help them to become aware of what is happening inside them, to adapt and to integrate into reality while maintaining a personal representation of what is fundamental to them.

With this call for proposals, the Huoshen Fund aims to support organisations developing psychophysical activities for adolescents in order to raise their awareness of the importance of taking care of their lives by learning a body-based practice under the guidance of qualified trainers.

Budget: 5.000 euro
Deadline: 06 January 2026

More information

The European Partnership for Personalised Medicine, EP PerMed supported by the European Union under Horizon Europe, Grant Agreement N° 101137129, has launched its first research, innovation and technology call (RITC2026) for proposals on “Test and Demonstration of Multimodal Data Approaches for Personalised Medicine”, acronym “MultiPMData2026”. In total, 19 funding organisations participate in this call with an available budget of over 14.8 Mio. € (approx.).

EP PerMed funding organisations, listed below, have agreed to jointly fund multinational innovative research and technology projects in personalised medicine (PM) to encourage innovative, interdisciplinary public-private partnerships and to support the translational and clinical implementation of research outcomes.

The call will be implemented in two stages, i.e. a pre- and a full proposal phase.

Belgium (FIO VLAIO)

Additional documents to be sent via the regional submission platform (E-Tool). Documents required for submission at VLAIO available at: https://www.vlaio.be/nl/media/1488 (ENG) or https://www.vlaio.be/nl/media/1490 (NL)

Belgium (SPW-EER)
Additional documents to be sent via the regional submission platform.

Deadline: 12 January 2026 (pre-proposal); 27 April 2026 (full-proposal)

Together with the partnership ‘Fostering a European Research Area for Health Research’ (ERA4Health), KCE Trials is happy to announce the “Trials4Health 2026” call will open on 6 November 2025.

This call provides funding for multi-country, comparative effectiveness or drug repurposing Investigator-Initiated Clinical Studies (IICS) in Cardiovascular, Autoimmune and Metabolic diseases. Deadline for submission will be 27 January 2026.

More information